Study Designed to Optimize the Treatment of Primary Pneumothorax (TOPP)
Thoracoscopic Treatment of Primary Pneumothorax - A National Randomised Controlled Trial
Sponsor: Danish Medical Association
This EARLY_PHASE1 trial investigates Pleural Disease and Primary Spontaneous Pneumothorax and is currently ongoing. Danish Medical Association leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown EARLY_PHASE1
-
Jan 2025 — Sep 2025 [monthly]
Unknown EARLY_PHASE1
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting Phase 0
First recorded
Mar 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Medical Association
- Danmarks Lungeforening
- Odense University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .